Navigation Links
Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
Date:10/1/2007

LOS ANGELES, Oct. 1 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN - News) has announced that is has completed in-house testing and technological evaluation of various new modules for its holter and intra- cardiac monitors - items that have previously been an important part of the Company's business plans and are now ready for submission to FDA for clearance. Applications for FDA approval will now be made imminently in the fourth quarter.

Both of these developments are ahead of schedule, and are of importance because they are both revenue producing as well as scientifically significant to the reduction of the $400 billion in cardiovascular expenses as well as to patient health and welfare. Having them completed ahead of schedule will likely bring these products to the forefront several quarters earlier than anticipated - both from a revenue standpoint as well as a scientific venturing standpoint.

About Signalife

Signalife, Inc. is a life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting.

Signalife is publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is http://www.Signalife.com. Clear Data. Trusted Results.

Caution Regarding Forward-Looking Statements

Statements in this release that are not strictly historical are "forward- looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and
'/>"/>

SOURCE Signalife, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
2. Celsion Completes Enrollment in Phase I Liver Cancer Study
3. LANI completes Phase I in Japan and to commence Phase I in UK
4. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
5. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
6. PSA TestingHow Much is Too Much?
7. Hemoglobin Testing at the Point of Care
8. Testing for Human Papillomavirus
9. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
10. Rapid HIV Testing Increases Possibility of Treatment
11. Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...S, Nov. 30 Nonin Medical, Inc., a ...tions and the inventor of fingertip pulse oximetry...ican Product Line Strategy Award in Remote Patient...rate remote physiological monitoring, Nonin Medica... provider of telemedicine monitoring equipment. ,...
(Date:11/30/2009)... Calif., Nov. 30 Nektar ...promotion of Lorianne Masuoka, M.D. to Senior Vice... will report directly to Nektar,s President and Ch...orianne,s outstanding leadership and highly effect...rumental in rapidly advancing Nektar,s proprietary...
(Date:11/30/2009)....J., Nov. 30 Covance Inc...ent at the Piper Jaffray 21st Annual Health Care C....m. (ET). Investors may access a live webcast of ...o register and download any necessary software, pl...headquarters in Princeton, New Jersey, is one of t...
Breaking Medicine Technology:Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 2Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 3Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3New species of phallus shaped mushroom named after California Academy of Sciences scientist 8844 1New species of phallus shaped mushroom named after California Academy of Sciences scientist 8844 2Hudson Institute Debates the Long Term Fiscal Impact of Health Care Reform 48949 1Hudson Institute Debates the Long Term Fiscal Impact of Health Care Reform 48949 2American Hospital Management Company Announces the Opening of the New HOSPITAL UNIVERSITARIO DEL RIO HOSPIRIO in Cuenca Ecuador 48945 1American Hospital Management Company Announces the Opening of the New HOSPITAL UNIVERSITARIO DEL RIO HOSPIRIO in Cuenca Ecuador 48945 2
...dy results presented at the Scoliosis Research Soc... Lake City, SALT LAKE CITY, Sept. 11 Researchers...have identified specific genetic markers,for scoli... for the,development of a DNA-based prognostic tes...olescent Idiopathic Scoliosis., This groundbreaki...
...KVILLE, Md., Sept. 11 Vanda,Pharmaceuticals Inc. ...sed on,the development and commercialization of cl...s system disorders, reported today that it met wit...operidone non-approvable action,letter that the co... arguments to support its belief that iloperidone,...
Other Medicine Technology:Researchers at Axial Biotech Develop a DNA Test for Scoliosis 2Vanda Pharmaceuticals Provides Update on Iloperidone 2Vanda Pharmaceuticals Provides Update on Iloperidone 3
(Date:12/1/2009)...1 Individuals in consum...n those with traditional coverage to exhibit a num...d in wellness programs, and to be more inclined to... down costs, according to survey results released ... Institute (EBRI). ,, At the same time, the fi...
(Date:12/1/2009)... Performing surgical operations without leaving s...eality. This is demonstrated by the recent surgica...luminal Endoscopy Surgery), an innovative surgical...dy,s natural orifices. The results are all advanta...ital stay and faster recovery. Currently, this typ...
(Date:12/1/2009)...enign versus cancerous lesions, researchers say ,...en used with ultrasound, elastography helps distin... which reduces unnecessary biopsies, U.S. research...sions that are biopsied turn out to be benign, acc...,s a lot of room to improve specificity with ultra...
(Date:12/1/2009)...FE, Calif., Dec. 1 The first nutri... grapes acclaimed for its potential to forestall t...e. ,, (Photo: http://www.newscom.com/cgi-bin/p...ewscom.com/cgi-bin/prnh/20091111/NY08935LOGO ) ,... ResVez, Inc. of Rancho Santa Fe, Calif. contains ...
(Date:12/1/2009)...c. 1 Gooooooaaaaaal! Cuties...its 2009/2010 growing season with a fresh starting... kids, soccer. Joy Fawcett - an award-winning soc...,s efforts to celebrate and mentor moms on the sid...p expansion into Texas and a community-based Web s...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 2Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 3Health News:Ultrasound With Elastography May Cut Down on Biopsies 2Health News:First Resveratrol Nutrition Bar Hits the Market 2Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 2Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 3Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 4
...COVER: "Giving Globally: How to Heal The World" (p...r people who, 211 years after Edward Jenner,immuni...ving vaccines to,children around the world in deve... which together take 6 million lives each,year -- ...
...ALLEGAN, Mich., Sept. 19 The Perrigo Company,(Nas...eived final approval,from the U.S. Food and Drug A... Topical Solution, 8% (Nail Lacquer). Shipments wi...ated for the,treatment of mild to moderate fungal ...
...Strengthens Position as the Global Leader in Endos.... 20 NDO Surgical, Inc. (NDO),announced that the ...Company,s Plicator II(TM) multiple implant technol...tients. "This clearance and the subsequent launch...
...U.S. Food and Drug Administration clears new impla...Innovations, Inc. (SBi),a single-source provider o... bone and joint sector of the orthopedic industry,...d, degradable,spacers to four applications with tw...
..., BOSTON Since the days of Hippocrates, people ha...he seasons. More recently, researchers have learne...as seasonality, are often related to the weather. ...the Department of Public Heath and Family Medicine...
...Insights might produce treatments to kill off canc...y News) -- New information about a process called ...he fight against heart disease, cancer, stroke and...unplanned cell death caused by outside factors, su...
Other Medicine News:Health News:NEWSWEEK: Media Lead Sheet: October 1, 2007 Issue (on newsstands Monday, Sept. 24). 2Health News:NEWSWEEK: Media Lead Sheet: October 1, 2007 Issue (on newsstands Monday, Sept. 24). 3Health News:NEWSWEEK: Media Lead Sheet: October 1, 2007 Issue (on newsstands Monday, Sept. 24). 4Health News:NEWSWEEK: Media Lead Sheet: October 1, 2007 Issue (on newsstands Monday, Sept. 24). 5Health News:Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution 2Health News:NDO Receives FDA 510(K) Clearance for Plicator II(TM) 2Health News:Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 2Health News:Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 3Health News:Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 4Health News:Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 5Health News:Mathematics might save you a trip to the ER 2Health News:Clues to Cell Death Could Fight Disease 2
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: